Skip to content

A COMPARATIVE PHARMACEUTICO-ANALYTICAL AND CLINICAL STUDY OF INDRAVATI AND VANGESHWARA RASA IN DIABETES

A COMPARATIVE PHARMACEUTICO-ANALYTICAL AND CLINICAL STUDY OF INDRAVATI AND VANGESHWARA RASA IN MADHUMEHA

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015829
Enrollment
40
Registered
2018-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: E08-E13- Diabetes mellitus

Interventions

Intervention1: INDRAVATI: RASA SINDOOR VANGA BHASMA ARJUN TWAK CHURNA SHALMALLI MOOL SWARASA Dose 62.5 mg bid, 2 Months Control Intervention1: VANGESHWARA RASA: RASA SINDOOR VANGA BHASMA Dose 125mg bi

Sponsors

NATIONAL INSTITUTE OF AYURVEDA JAIPUR
Lead Sponsor
MINISTRY OF AYUSH
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between the ages 30 to 60 years of either sex irrespective of chronicity will be taken 2. Presence of cardinal symptoms of Madhumeha described in Ayurveda classics 3. Confirmed cases of DM type II on the basis of laboratory investigations and observed sign and symptoms 4. Patients having FBS level ranges between 126 – 200 mg/dl and PPBS between 200 – 300 mg/dl will be selected for the study.

Exclusion criteria

Exclusion criteria: 1.Patient with type 1 Diabetes mellitus 2.Patients with type 2 Diabetes mellitus who are on insulin 3.Patients of Gestational Diabetes and Juvenile Diabetes 4.Patient having Type-II DM with any other serious systemic disease 5.Patients with complications like cardiac disorder, diabetic foot Nephropathy and other secondary complications. 6.Diabetes Mellitus produced due to other illnesses like Acromegaly Cushing’s syndrome pancreatic disorders etc.

Design outcomes

Primary

MeasureTime frame
PrabhutaMootrata AavilMootrata Atitrishna and Dourbalya Karapadadahaand Timepoint: 30TH DAY 60TH DAY

Secondary

MeasureTime frame
Blood sugar level-Fasting and post prandial Timepoint: 30TH DAY 60TH DAY

Countries

India

Contacts

Public ContactDR KANCHAN SWAMI

NATIONAL

drkanchanswami@gmail.com9461056605

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026